Montalbano Innovation & Development (MIDI), Inc.
MIDI is an award winning strategic turnkey, FDA and ISO compliant product development consulting firm with over 45 years experience servicing domestic and international clientele representing medical, life sciences, and home healthcare markets.
MIDI’s multi-disciplined, talented group achieves innovative results within rapid time lines under stringent regulatory constraints. MIDI’s dedicated teams of research, design and engineering professionals offer a unique combination of talent and experience, consisting of key personnel working together with a record of outstanding achievement in developing Class I, II and III products.
Their proprietary DevelopmentDNA™ approach to product development provides clients with a distinguished thoroughness in securing product results that answer market needs and increase sales as well as market share.
From the first idea to the last detail, they balance technical information with strong orientation toward user-driven design solutions. Our disciplines blend all technical/IP and human requirements. This combination is maintained with a proper balance of research methods, design, engineering, cost-effective implementation, manufacturing knowledge, DFX, regulatory compliance, and the wherewithal to use the aforementioned disciplines in concert.
The Quantlet Concept Was Developed By
Dr. Kruse is a respected neurosurgeon and CEO of Optimized Life, a health and wellness company dedicated to helping patients avoid the healthcare burdens we typically encounter as we age. He is currently in private practice in the Gulf South.
Light Module Development
James is Founder & CEO of THOR Photomedicine and an acknowledged world expert on the effect of light on cellular function. James' role is to develop the best possible light parameters for maximizing the effects from a wearable device.
Dr. Michael R. Hamblin PhD
Dr. Hamblin is Associate Professor of Harvard Medical School, a Principal Investigator at the Wellman Center for Photomedicine and an authority in Photobiomodulation. He has published 286 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 8 patents.
Dr. Theodore Achacoso MD
Dr. Achacoso is a fellow of Interventional Neuroradiology, a Research Professor of Pharmacology, and a Clinical Professor of Neurology. He was a Professor of Medical Informatics and of Neurointerventional Radiology in Washington, DC. He is published in peer-reviewed scientific journals and holds several US patents.
Dr. Daianne T. Meneguzzo PhD
Dr. Meneguzzo is actively involved in both research and clinical practice in Photobiomodulation. She obtained her Doctorate degree at the Lasers & Applications Center of the University of Sao Paolo (Brazil) and has advanced degrees in dentistry and laser acupuncture therapy. She is a world expert in transcutaneous blood irradiation.
WE ARE NO LONGER ACCEPTING ORDERS FOR THE NEXT PRODUCTION BATCH. Dismiss